Therapeutic agent for chronic obstructive pulmonary disease

Details for Australian Patent Application No. 2006241774 (hide)

Owner Dainippon Sumitomo Pharma Co., Ltd.

Inventors Nakajima, Takashi; Fujita, Hitoshi; Kanai, Toshio; Sugasawa, Toshinari

Agent Davies Collison Cave

Pub. Number AU-B-2006241774

PCT Pub. Number WO2006/118268

Priority 2005-154008 26.05.05 JP; 2005-132871 28.04.05 JP

Filing date 28 April 2006

Wipo publication date 9 November 2006

Acceptance publication date 15 September 2011

International Classifications

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/5377 (2006.01)

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/118268 Priority application(s): WO2006/118268

15 September 2011 Application Accepted

  Published as AU-B-2006241774

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006241793-Method for determination of cholesterol in high-density lipoprotein

2006241771-Composition containing anti-dementia drug